PolyPid Ltd.
(NASDAQ : PYPD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.13%144.370.7%$909.71m
PFEPfizer Inc. -0.91%37.150.9%$777.51m
BMYBristol-Myers Squibb Co. -0.69%60.221.0%$639.89m
MRKMerck & Co., Inc. 0.08%78.330.7%$630.18m
ABBVAbbVie, Inc. -1.67%82.841.9%$581.14m
LLYEli Lilly & Co. -1.17%141.911.1%$494.92m
AZNAstraZeneca Plc 0.17%52.281.2%$201.47m
NVSNovartis AG -1.32%84.560.2%$143.71m
GSKGlaxoSmithKline Plc -1.24%35.600.2%$134.49m
NVONovo Nordisk A/S -0.27%71.060.1%$70.76m
RGENRepligen Corp. -0.21%172.137.1%$63.28m
RPRXRoyalty Pharma Plc -2.72%39.000.2%$57.60m
SNYSanofi -1.06%49.350.2%$48.24m
PRAXPraxis Precision Medicines, Inc. 1.01%28.030.0%$47.88m
AMAGAMAG Pharmaceuticals, Inc. 0.15%13.6622.1%$44.90m

Company Profile

PolyPid Ltd. is a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes. The company was founded by Noam Emanuel in 2008 and is headquartered in Petach Tikva, Israel.